2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1023436391 M.D.
Verify on CMS →

JOHN LING, M.D.

Glaucoma Specialist (Ophthalmology) Physician in LAKEWOOD, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 933 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.8824/100
▲ 9 pts above national avg 83.1 · [object Object]
Industry payments
$492.95
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JOHN LING, M.D. reported a CMS MIPS final score of 91.8824/100 — above the 83.1 national average — and filed 4,571 Medicare Part D claims in 2023.

91.8824/100
MIPS score · +9 vs avg
5K
Part D claims, 2023
64%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN LING, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

92 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JOHN LING, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN LING, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/02/2014

NPI 1023436391

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

4,571 54% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

91.8824/100 8.78240000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Glaucoma Specialist (Ophthalmology) Physician share within California

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within California

Medicare quality performance — MIPS

JOHN LING, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
91.8824/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 91.8824/100 vs national avg 83.1

0%100%National avg83%91.9%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 91.8824/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN LING, M.D. is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in LAKEWOOD, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1023436391. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JOHN LING, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 3300 E SOUTH ST STE 105, LAKEWOOD, CA, 90805, with a listed phone of (562) 531-2020. NPI 1023436391 was issued on 04/02/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LING most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,571 prescription claims written by this provider, covering 933 Medicare beneficiaries and totaling roughly $603K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.8824/100 for the 2023 performance year (Quality 100, Cost 72.9414), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3300 E SOUTH ST STE 105
LAKEWOOD, CA 90805

Provider Details

NPI 1023436391
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 04/02/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.8824
Final Score
Avg: 83.1
100
Quality
72.9414
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where JOHN LING, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LAKEWOOD EYE PHYSICIANS AND SURGEONS INC A MEDICAL GROUP
LAKEWOOD, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOHN LING, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$493

Largest payer

NEW WORLD MEDICAL,INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to JOHN LING, M.D.. To verify JOHN LING, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JOHN LING, M.D. — brand share 36.0%
Specialty average (est.)

36% brand-name claims vs 64% generic, on 4,571 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,571
Total Claims
$603K
Total Drug Cost
933
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,564
Total Day Supply
277,139
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$462K
Generic Drug Cost
$141K
Antibiotic Claims
11

Patient Demographics

Average Patient Age
77.2 years
Avg HCC Risk Score
1.64
Gender Split
55% female / 45% male
Age Distribution
<65: 33, 65-74: 335, 75-84: 384, 85+: 181

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
1,073
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
774
Prednisolone Acetate
395
Brimonidine Tartrate
321
Timolol Maleate
280
Ketorolac Tromethamine
274
Ofloxacin
270
Dorzolamide Hcl
136
Rocklatan
Netarsudil Mesylat/Latanoprost
103
Lumigan
Bimatoprost
102

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How JOHN LING, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

JOHN LING, M.D.'s 4,571 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as LING.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN LING, M.D.'s specialty?
JOHN LING, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in LAKEWOOD, California. Credentials: M.D..
How much does JOHN LING, M.D. prescribe under Medicare Part D?
In 2023, JOHN LING, M.D. wrote 4,571 Medicare Part D claims totaling $603K in drug costs for 933 beneficiaries.
What is JOHN LING, M.D.'s Medicare quality score?
JOHN LING, M.D. has a CMS MIPS Final Score of 91.8824/100 (Quality: 100, Cost: 72.9414). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOHN LING, M.D. located?
JOHN LING, M.D. is located at 3300 E SOUTH ST STE 105, LAKEWOOD, CA, 90805. Phone: (562) 531-2020.
What is JOHN LING, M.D.'s NPI number?
JOHN LING, M.D.'s National Provider Identifier (NPI) is 1023436391, issued on 04/02/2014.
Does JOHN LING, M.D. prescribe more brand-name or generic drugs?
JOHN LING, M.D.'s prescribing is 36% brand-name and 64% generic drugs by claim count, with $462K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does JOHN LING, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOHN LING, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN LING, M.D. accept Medicare?
JOHN LING, M.D. appears in CMS Medicare data with 4,571 Part D claims and 933 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN LING, M.D.'s credentials?
JOHN LING, M.D.'s NPI is 1023436391 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology